3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
40
HER2 Positive Metastatic Breast Cancer
4
Breast Diseases
4
Brain Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
HER2-positive Breast Cancer
2
Colorectal Neoplasms
2
Advanced Breast Cancer
2
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Salivary Gland Neoplasms
1
Pathologic Complete Response
1
Neoplasm Metastasis
1
Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
1
HER2-positive Metastatic Breast Cancer
1
HER2+ Early or Locally Advanced Breast Cancer
1
HER2+ Breast Cancer
1
HER2 Positive Gastric Cancer
1
HER2 Positive Breast Cancer
1
HER-2 Positive Colorectal Cancer
1
Estrogen Receptor-positive Breast Cancer
1
Digestive System Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
pyrotinib
1
palbociclib
1
Trastuzumab
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Estrogen Receptor-positive Breast Cancer
×
pyrotinib
×
Clear all
NCT05076695
2021-10-13
NeoTPPF
Fudan University
Phase 2
Unknown
37 enrolled